2020 PHARMA-DEKO PLC

2020 2019 2018 2017 2016
N. '000 N. '000 N. '000 N. '000 N. '000

StatementofFinancial Position 1,663,711 1,733,933 1,812,288 1,736,358 1,744,661
353,345 463,469 510, 849 534,237 579,383
Assets
Non -current assets 2,017,056 2,197,402 2,323,137 2,270,595 2,324,044
Current assets
Total assets

Liabilities 18,071 246,887 186,991 100,068 100,349
Non -current liabilities 1,012,719 639,042 545,790 427,991 482,900
Current liabilities
1,030,790 885,929 732,781 528,059 583,249
Total liabilities

Equity 488,475 488,475 488,475 488,475 488,494
Sharecapital 1,365,223 1,365,223 1,365,223 1,241,432 1,241,432
Revaluationreserve (867,432) (542,225) (263,342)
Retainedincome 12,629 10,869
986,266 1,311,473 1,590,356
Total equity 1,742,536 1,740,795
2,017,056 2,197,402 2,323,137
Total equityandliabilities 2,270,595 2,324,044

Statement of Profit or LossandOther Comprehensive Income 460,837 484,57 4 1,023,806 1,593,379 1,481,964
(404,963) (312,617) (622,439) (830,230) (769,751)
Revenue
Cost ofsales 55,874 171,957 401,367 763,149 712,213
4,556 90,668 11,223 3,383 885,443
Grossprofit 756
Other operating income 30 764 7 5,615
Other operating gains (losses) (382,302) (532,398) (667,642) (727,974) (1,311,458)
Other operating expenses
(321,842) (269,009) (255,045) 39,314 291,813
Operating(loss) profit (2,212) (7,451) (938) - -
Financecosts - - - - -
Derecognitionof loanliability
(324,054) (276,460) (255,983) 39,314 291,813
(Loss) profit before taxation (1,152) (2,423) (9,277) (26,709) (42,410)
Taxation
(325,206) (278,883) (265,260) 12,605 249,403
(Loss) profit fromcontinuedoperations
(325,206) (278,883) (265,260) 12,605 249,403
(Loss) profit for the year
(325,206) (278,883) (265,260) 12,605 249,403
Retained (loss) income for the year

































81